跳至主要内容
临床试验/RPCEC00000360
RPCEC00000360尚未招募未知

INTERVENTIONAL TRIAL TO EVALUATE DIRECT AND INDIRECT EFFECTS OF VACCINATION ANTI SARS COV 2 IN POPULATION COHORT AT RISK OF INFECTION, DISEASE AND DISPERSION OF THE EPIDEMIC (COVID-19) - SOBERANA - INTERVENTIO

Finlay Vaccine Institute (IFV)0 个研究点开始时间: 2021年3月19日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Prevention

入排标准

年龄范围
19 years 至 80 years(—)
性别
All

入选标准

  • 1. Both sexes.
  • 2. Age between 19 and 80 years, extremes are included.
  • 3. Subjects who grant their consent to participate

排除标准

  • 1. Individuals previously vaccinated with a vaccine candidate or SARS-CoV-2 vaccine.
  • 2. Documented history of previous COVID-19 infection as a result of medical questioning.
  • 3. Allergy to any of the components of the vaccine.
  • 4. Administration of immunomodulators in the 30 days prior to vaccination.
  • 5. Decompensated chronic diseases that limit vaccination.
  • 6. Pregnancy, childbirth and the puerperium.
  • 7. Acute illness that contraindicates vaccination
  • 8. HIV subjects with detectable viral load, history of opportunistic infection or CD4 less than 200 copies.
  • 9. For the application of the booster dose, subject with a history of being convalescent of COVID, or having less than 5 months of the last dose applied.

研究者

发起方
Finlay Vaccine Institute (IFV)

相似试验

SOBERANA - INTERVENTIO | 临床试验